⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

WAT

Waters Corporation

Healthcare · Diagnostics & Research

404.81USD

+1.9000 (+0.47%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
1)

Comparable Revenue

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY3.0B3.0B3.0B3.2B6.5B7.1B
Q1690.6M684.7M636.8M661.7M1.3B—
Q2714.3M740.6M708.5M771.3M1.6B—
Q3708.6M711.7M740.3M799.9M1.8B—
Q4858.5M819.5M872.7M932.4M1.8B—
2)

Comparable Earnings Per Share

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY.007.007.007.00714.5816.55
Q1.002.001.001.001-.728—
Q2.002.002.001.002-1.39—
Q3.002.001.002.0024.00—
Q4.002

Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.

.002
.002
.002
4.67
—